WASHINGTON, Oct. 24, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc.(Vanda) (NASDAQ: VNDA) today announced it will release results for the third quarter of 2017 on Tuesday, November 7, 2017, after the market closes.
Vanda will host a conference call at 4:30
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Tuesday, November 7, 2017, beginning at 7:00 PM ET and will be accessible until Tuesday, November 14, 2017, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 45886211.
ABOUT VANDA PHARMACEUTICALS INC.:Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.
Investor Contact:Jim KellyExecutive Vice President & Chief Financial OfficerVanda Pharmaceuticals Inc.(202) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2017-financial-results-on-november-7-2017-300541649.html
SOURCE Vanda Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Bubonic plague is an infectious disease caused by the bacteria Yersinia pestis present in rodents ...
Steroids are miracle drugs but have to be used with caution. Some steroids are illegal to use, ...
Abruptio placenta is a serious but rare complication of pregnancy where a separation of placenta ...View All